FDA Adverse Event Injury Summary report: N

CALSTRUX (TRICALCIUM PHOSPHATE)

MDR report key: 1414433 · Received July 13, 2009

Report

Report Number
1224732-2009-00043
Event Type
Injury
Date Received
July 13, 2009
Report Date
July 1, 2009
Manufacturer
STRYKER BIOTECH
Product Code
MPY
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL CATALOG NUMBER: 40015, LOT NUMBER: TU07017.

Description of Event or Problem · 1

ON 04/21/2009, STRYKER BIOTECH RECEIVED A REPORT THAT A FEMALE PATIENT WHO RECEIVED AN UNKNOWN OP-1 CONTAINING PRODUCT IN 2007, AS PART OF A REVISION PROCEDURE TO TREAT FLATBACK SYNDROME DEVELOPED A POSTOPERATIVE INFECTION IN AN UNSPECIFIED LOCATION. THE PHYSICIAN REPORTED THAT THE INFECTION WAS SERIOUS, REQUIRING HOSPITALIZATION, AND THAT A 'SURGICAL EXPLORATION' WAS PERFORMED. HE ALSO STATED THAT WHILE HE BELIEVED THE EVENTS TO BE SERIOUS, HE DID NOT BELIEVE THEY WERE RELATED TO THE USE OF THE PRODUCT OF INTEREST. THE PHYSICIAN REPORTED THAT THE PATIENT RECOVERED FROM THE EVENTS. THE PATIENT, WHO HAS BEEN DIAGNOSED WITH DIABETES MELLITUS, HAS A MEDICAL HISTORY, WHICH INCLUDED OSTEOMYELITIS AND AN EPIDURAL ABSCESS. ADDITIONAL INFORMATION WILL BE REQUESTED. ON 07/01/2009: ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION FROM THE REPORTER WERE MADE ON 05/08/2009, 05/21/2009 AND 06/08/2009, BUT NO ADDITIONAL INFORMATION HAS BEEN RECEIVED. INVOICE DOCUMENTATION SUBMITTED BY THE HOSPITAL TO STRYKER BIOTECH INDICATED THAT A PATIENT WITH THE SAME INITIALS, GENDER, AND DATE OF PROCEDURE RECEIVED THE FOLLOWING PRODUCTS: 7 UNITS OF OP-1 PUTTY, CATALOG NUMBER 30050; 1 UNIT CALSTRUX, CATALOG NUMBER 40010, AND 2 UNITS CALSTRUX, CATALOG NUMBER 40015. THIS MDR REPORT REFLECTS THE CALSTRUX DEVICE USAGE. SEE MDR 1224732-2009-00033, WHICH CAPTURES THE OP-1 PUTTY DEVICE USAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CALSTRUX (TRICALCIUM PHOSPHATE) IMPLANT MPY STRYKER BIOTECH NA TU07018

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| R